Dr. Rebekah Gensure is a Salt Lake City, Utah based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Rebekah Gensure is 10507952-1205 in Utah. Dr. Rebekah Gensure is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Rebekah Gensure speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D., PH.D.
Gender:
Female
Practice Address:
755 E 3900 S, Salt Lake City, Utah, 84107-2176
Phone:
801-266-2283
Fax:
801-268-6151
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1225490444
NPI Enumeration Date:
26 Mar, 2016
NPI Last Update On:
13 Sep, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Rebekah Gensure are as mentioned below.
License Number
Specialization
State
Status
10507952-1205
Utah
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
755 E 3900 S, Salt Lake City, Utah
Zip:
84107-2176
Phone Number:
801-266-2283
Fax Number:
801-268-6151
Patients can reach Dr. Rebekah Gensure at 755 E 3900 S, Salt Lake City, Utah or can call to book an appointment on 801-266-2283. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.